July 13, 2016 BY Valentina Kirilova
GenSight Biologics listed on Euronext's regulated market in Paris
The Euronext subsidiary EnterNext, dedicated to promoting and growing the market for small and medium-sized companies (SMEs), today has welcomed GenSight Biologics, a biopharmaceutical specialist in gene therapy, for its first day of trading on compartment C of Euronext’s regulated market in Paris. Founded in 2012, GenSight Biologics is a company dedicated to discovering and…
Read more